Nucleus-Targeted, Echogenic Polymersomes for Delivering a Cancer Stemness Inhibitor to Pancreatic Cancer Cells
Authors:
- Fataneh KarandishFKFataneh Karandish
- Babak MamnoonBMBabak Mamnoon
- Li FengLFLi Feng
- Manas K. HaldarMHManas K. Haldar
- Lang XiaLXLang Xia
- Kara N. GangeKGKara N. Gange
- Seungyong YouSYSeungyong You
- Yongki ChoiYCYongki Choi
- Sanku MallikSMSanku Mallik
- 31 August 2018
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 19 (10) , 4122-4132
Abstract
Chemotherapeutic agents for treating cancers show considerable side effects, toxicity, and drug resistance. To mitigate the problems, we designed nucleus-targeted, echogenic, stimuli-responsive polymeric vesicles (polymersomes) to transport and subsequently release the encapsulated anticancer drugs within the nuclei of pancreatic cancer cells. We synthesized an alkyne-dexamethasone derivative and conjugated it to N3–polyethylene glycol (PEG)–polylactic acid (PLA) copolymer employing the Cu2+ catalyzed “Click” reaction. We prepared polymersomes from the dexamethasone–PEG–PLA conjugate along with a synthesized stimuli-responsive polymer PEG–S–S–PLA. The dexamethasone group dilates the nuclear pore complexes and transports the vesicles to the nuclei. We designed the polymersomes to release the encapsulated drugs in the presence of a high concentration of reducing agents in the nuclei of pancreatic cancer cells. We observed that the nucleus-targeted, stimuli-responsive polymersomes released 70% of encapsulated contents in the nucleus-mimicking environment in 80 min. We encapsulated the cancer stemness inhibitor BBI608 in the vesicles and observed that the BBI608 encapsulated polymersomes reduced the viability of the BxPC3 cells to 43% in three-dimensional spheroid cultures. The polymersomes were prepared following a special protocol so that they scatter ultrasound, allowing imaging by a medical ultrasound scanner. Therefore, these echogenic, targeted, stimuli-responsive, and drug-encapsulated polymersomes have the potential for trackable, targeted carrier of chemotherapeutic drugs to cancer cell nuclei.Keywords
Funding Information
- North Dakota State University
- National Institute of General Medical Sciences (1R01 GM114080)
- Division of Materials Research (DMR 1306154)
This publication has 59 references indexed in Scilit:
- In vitro measurement of attenuation and nonlinear scattering from echogenic liposomesUltrasonics, 2012
- Acoustic characterization of echogenic liposomes: Frequency-dependent attenuation and backscatterThe Journal of the Acoustical Society of America, 2011
- Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene deliveryJournal of Controlled Release, 2011
- Redox Control Systems in the Nucleus: Mechanisms and FunctionsAntioxidants & Redox Signaling, 2010
- A Generalized System for Photoresponsive Membrane Rupture in PolymersomesAdvanced Functional Materials, 2010
- Stability analysis of an encapsulated microbubble against gas diffusionJournal of Colloid and Interface Science, 2010
- Growth and Dissolution of an Encapsulated Contrast Microbubble: Effects of Encapsulation PermeabilityUltrasound in Medicine & Biology, 2009
- A review of stimuli-responsive nanocarriers for drug and gene deliveryJournal of Controlled Release, 2008
- Nuclear envelope barrier leak induced by dexamethasoneJournal of Cellular Physiology, 2005
- Improving ultrasound reflectivity and stability of echogenic liposomal dispersions for use as targeted ultrasound contrast agentsJournal of Pharmaceutical Sciences, 2001